Brooklyn Bodega Peptide Vials Tested and Found to Lack Active Ingredients
Vials sold as injectable peptides at a Brooklyn bodega were lab-tested and shown to contain none of the claimed compounds.
A consumer purchase of four injectable peptide vials from a Brooklyn bodega was examined by an independent lab that specializes in purity testing. While the samples showed only minimal heavy metals and endotoxins, none contained the substances listed on their labels, indicating either mislabeling or degradation due to improper storage. Industry experts note that many peptide products are sold without regulatory approval and often bear a "research use only" disclaimer to avoid liability.
Similar testing by other buyers has produced comparable results, pointing to a network of low-quality suppliers serving multiple storefronts. The episode underscores concerns from pharmacists and regulatory advocates about the safety and legality of peptide sales in brick-and-mortar venues.
Why it matters
Consumers may be paying for ineffective or unsafe products sold as medical peptides.
In this story
